Tackling Antimicrobial Resistance: One for All, and All for One

Dear Colleagues,

At the end of the previous century, the discovery of antimicrobial resistance (AMR) added a burden to both the local and global health community. Tackling such an issue requires up-to-date evidence, research, and field experiences. Here, we present a Special Issue that focuses on methods, previous results, and active measurements to tackle AMR. This approach also includes the chance to dig deep into the mechanisms by which some organisms develop AMR. In presenting such academic works to the scientific community, our aim is to translate knowledge and set waypoints for future research.

Whenever viruses, bacteria, fungi or any medically relevant microorganisms develop resistance to treatment protocols, the aftermath is taxing to the health and medical profession. A minor sway from standard procedure, negligence in following guidelines, simply overlooking something due to overexertion, or burnout from long hours of work may result in spending considerably more than would have been spent in preventing such circumstances. Preventing the advancement of AMR is an important strategy to tackle the issue, such as promoting sanitation or improving immunity (e.g., vaccination). Several cutting-edge medical advancements are in the making, as seen with the testing of phages, lysins, or peptides to tackle AMR either through treatment or prevention.

Until such advancements are applicable, the health and medical profession is still actively tackling AMR through applying appropriate practices (e.g., guidelines and stewardship programs), conducting investigations (e.g., rapid testing or for surveillance), and improving health service infrastructure (addressing related health determinants). The way forward is to find new practical and affordable ways to tackle AMR as sustainable solutions.

Dr. Hamid Bokhary
Dr. Mohammed Imam
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Tropical Medicine and Infectious Disease is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.